...
首页> 外文期刊>International Journal of Pharmaceutics >Vesicular systems in ocular drug delivery: an overview.
【24h】

Vesicular systems in ocular drug delivery: an overview.

机译:眼部药物输送中的囊状系统:概述。

获取原文
获取原文并翻译 | 示例

摘要

The main aim of pharmacotherapeutics is the attainment of effective drug concentration at the intended site of action for a sufficient period of time to elicit a response. Poor bioavailability of drugs from ocular dosage form is mainly due to the tear production, non-productive absorption, transient residence time, and impermeability of corneal epithelium. Though the topical and localized application are still an acceptable and preferred way to achieve therapeutic level of drugs used to treat ocular disorders but the primitive ophthalmic solution, suspension, and ointment dosage form are no longer sufficient to combat various ocular diseases. This article reviews the constraints with conventional ocular therapy and explores various novel approaches, in general, to improve ocular bioavailability of the drugs, advantages of vesicular approach over these and the future challenges to render the vesicular system more effective.
机译:药物治疗的主要目的是在足够长的一段时间内达到预期的作用部位有效药物浓度,以引起反应。眼剂型药物的生物利用度差主要是由于泪液的产生,非生产性吸收,短暂的停留时间和角膜上皮的不渗透性。尽管局部和局部应用仍然是达到用于治疗眼部疾病的药物的治疗水平的可接受且优选的方式,但是原始的眼科溶液,悬浮液和软膏剂型不再足以抵抗各种眼部疾病。本文回顾了常规眼治疗的局限性,并探索了各种新颖的方法,通常可以改善药物的眼生物利用度,囊泡方法相对于这些方法的优势以及使囊泡系统更有效的未来挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号